Stephen Foley: The best prescription for pharma firms
Saturday 12 June 2010
US Outlook: It was a legal battering in the US over the depression medicine Paxil that bounced GlaxoSmithKline into setting up an online register of all its clinical trial data, regardless of whether it had pushed to have the results of a study published in a medical journal. The company had been accused of burying studies which showed the medicine was less effective or more dangerous.
The drug industry has come a long way in the six years since then, but not far enough, which was why a couple of announcements this week are welcome, if insufficient, steps towards greater transparency. On Thursday, the industry's international trade body agreed a code of practice that commits companies to publishing all late-stage clinical trials, rather than cherry-picking. And yesterday, major drug companies signed up to share some of the data from trials of experimental Alzheimer's disease treatments, so that their scientists would find it quicker and easier to judge which treatments are working.
Both developments are welcome but incomplete. The international agreement could cover all trials, not just the big Phase III studies. The Alzheimer's collaboration needn't be limited just to data on patients using placebo. Its organisers promise similar agreements on Parkinson's disease work, but it could be extended across most disease areas.
The moral case for greater transparency and co-operation is unassailable: it prevents mischief and speeds up the development of vital new medicines. The business case is also strong and getting stronger: the fact that pharma companies are all duplicating the same basic research is a waste of resources for an industry suffering relentless pressure on costs.
- 1 Mother fed her daughter tapeworms to make her skinny for beauty pageant
- 2 Richard Dawkins on babies with Down Syndrome: 'Abort it and try again – it would be immoral to bring it into the world'
- 3 Crystal Palace next manager latest: Palace consider Ally McCoist - EXCLUSIVE
- 4 ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
- 5 Tim Sherwood column: 'It started as a three-horse race but turned into the Grand National'
'Alien thigh bone' on Mars: Excitement from alien hunters at 'evidence' of extraterrestrial life
West poised to join forces with Assad in face of Islamic State
Pamela Anderson rejects ice bucket challenge because of ALS experiments on animals: 'Mice had holes drilled into their skulls'
James Foley 'beheaded': Isis video shows militant with British accent 'execute US journalist' – as hunt begins for killer
ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
Richard Dawkins on babies with Down Syndrome: 'Abort it and try again – it would be immoral to bring it into the world'
Scottish independence: English people overwhelmingly want Scotland to stay in the UK
Isis threat: Cameron wants an alliance with Iran
Michael Brown shooting: Chaos erupts on the streets of Ferguson after autopsy shows teenager was shot six times – twice in the head
Disgusting, frustrating, but intriguing: how the country really feels about its politicians
Bin bag full of cats' heads discovered near Manchester's Curry Mile
iJobs Money & Business
£20000 - £27000 per annum: Harrington Starr: Service Desk Analyst- (Desktop Su...
£25000 - £35000 per annum: Harrington Starr: Service Desk Analyst - (Active Di...
£30000 - £50000 per annum: Harrington Starr: Junior Quant Analyst - C++, Boost...
£30000 - £50000 per annum: Harrington Starr: Junior Quant Analyst (Machine Lea...